Evidence map›Paper›PMID 41778892›Full record

ArticleAmerican journal of epidemiology2026

Use of the test-negative design to estimate the protective effect of a scalar immune measure: a simulation analysis.

Ziyuan Zhang, Christopher B Boyer, Marc Lipsitch

Abstract read
In one paragraph

Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ziyuan ZhangDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.ORCID 0000-0003-3488-5903
Christopher B BoyerDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.ORCID 0000-0002-1101-2045
Marc LipsitchDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.ORCID 0000-0003-1504-9213

Funding

Casual, Statistical and Mathematical Modeling with Serologic DataU01CA261277 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM, LIPSITCH, MARC · 2020 to 2023
$2.8M
NCI NIH HHS U01 CA261277NCI NIH HHS U01CA261277
6 · The paper itself

Abstract

Exposure-proximal antibody levels, or scalar correlates of protection (COPs), are increasingly used to assess infection risk following vaccination or prior infection. A version of the test-negative design (TND), adapted from vaccine effectiveness studies, has been proposed to estimate this relationship, but its validity for continuous immune measures under realistic epidemic conditions remains unclear. We used individual-based transmission models incorporating waning and boosting immunity and simulated two scenarios: one with homogenous baseline risk and another with a high-risk group. Infection risk was modeled as a function of COP, both linearly and nonlinearly. Test-negative design samples were drawn from single or multiple days and analyzed using logistic regression and generalized additive models (GAMs). Model validity, defined as the ability to recover the true COP-infection incidence rate ratio relationship, was evaluated using mean absolute error. Transformed logistic regression recovered the true relationship when the correct functional form was known, including in the presence of confounding. When the parametric model was misspecified, GAMs outperformed logistic regression, particularly with large sample sizes and broad COP coverage. Because the true functional form is often unknown, flexible semiparametric approaches may be preferred in well-powered TND studies with antibody measurements.

Indexed as

Vaccine EfficacyComputer SimulationHumansLogistic ModelsModels, StatisticalRiskVaccinationcorrelates of protectiongeneralized additive modelmisspecificationtest-negative designwaning

Identifiers

PMID41778892
PMCPMC13149011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.